The ongoing COVID-19 pandemic is associated with substantial morbidity and mortality.
While much has been learned in the first months of the pandemic, many features of COVID …

The ongoing coronavirus disease 2019 (COVID-19) pandemic is associated with substantial
morbidity and mortality. Although much has been learned in the first few months of the …

Anosmia was identified as a hallmark of COVID-19 early in the pandemic, however, with the
emergence of variants of concern, the clinical profile induced by SARS-CoV-2 infection has …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for a
pandemic affecting billions of people worldwide. Apart from the extreme global economic …

Complement system in COVID-19/P. Conigliaro et al. ed that in H5N1-infected mice the ALI
was related with an abnormal activation of CS in lung tissue. In H5N1-infected mice, the …

Anosmia, the loss of the sense of smell, is one of the main neurological manifestations of
COVID-19. Although the SARS-CoV-2 virus targets the nasal olfactory epithelium, current …

Anosmia, a total or partial loss of the ability to smell, is one of the most frequently
documented sequelae of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) …

The development of a tractable small animal model faithfully reproducing human
coronavirus disease 2019 pathogenesis would arguably meet a pressing need in …

The original version read “Here we show that all evaluated SARS-CoV-2 viruses (Wuhan,
Gamma, Delta and Omicron/BA. 1), including novel generated recombinant SARS-CoV-2 …

SARS-CoV-2 is the causative agent of COVID-19 and human infections have resulted in a
global health emergency. Small animal models that reproduce key elements of SARS-CoV-2 …